Deadly Spin Strikes a Chord

Deadly Spin book coverIn 2007, Los Angeles transplant surgeon Pauline Chen., M.D. found herself riveted by the case of Nataline Sarkisian, a 17 year old girl desperately in need of a liver transplant. Nataline suffered from recurrent leukemia that required aggressive medical treatment, but the treatment, while successful, had made her liver fail. Doctors recommended a liver transplant, saying it would give Nataline a 65 percent chance of living. Without the transplant, though, her death was certain. Shortly after doctors put Nataline's name on the transplant list, a perfectly-suited liver became available, but then her survival was no longer dependent on her doctors, the hospital or even the new liver that awaited her. It depended upon her health insurer, CIGNA, which denied Nataline's doctors' request to perform the transplant.

Lorillard Buys "MentholKillsMinorities.com"

BoldColdNewportLorillard, Inc., manufacturer of the country's best-selling menthol cigarette, Newport, is working  behind the scenes to keep the U.S. Food and Drug Administration (FDA) from banning menthol as a cigarette flavorant. Adopting a PR tactic other embattled companies like Bank of America and Altria have used, Lorillard is scooping up a host of menthol-bashing domain names to keep them out of the hands of critics, including MentholKills.com, KillerMenthol.com, MentholKillsMinorities.com and MentholAddictsYouth.com. Menthol acts as a mild local anesthetic in the throat, which critics say masks the harsh taste of cigarettes and makes them more appealing to younger users. Studies show that menthol cigarettes are disproportionately popular among African Americans, a group that also has a higher rate of smoking-related disease than the general population. An FDA advisory panel is scheduled to decide in March whether to
recommend ditching menthol in cigarettes across the board, including
Lorillard's flagship brand. Congress passed legislation in 2009 giving FDA more power to regulate tobacco, including artificial flavorants.

No

Pages

Subscribe to PR Watch RSS